Vitamin C in Post-cardiac Arrest
Key facts
- Who runs it
- Amsterdam UMC, location VUmc
- Where
- Netherlands1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 270 people enrolled
- Started
- 7 Oct 2019
- Ended
- 29 Aug 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Vitamin C
- Thiamine
- Placebos
- Record updated
- 10 March 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- An out-of-hospital cardiac arrest with return of spontaneous circulation
- Ventricular fibrillation or ventricular tachycardia as first registered cardiac rhythm
- Glasgow Coma Scale (GCS)-score ≤8
Who cannot take part
- Patients with pre-existent terminal renal insufficiency
- History of urolithiasis, oxalate nephropathy or hemochromatosis
- Known glucose 6-phosphate dehydrogenase deficiency (risk of hemolysis)
- Treatment limitations
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Only half of the patients suffering from cardiac arrest arrive at the hospital alive. Of these survivors, more than 50% will still die or remain severely disabled. During cardiac arrest ischemia causes damage to the vital organs, especially the brain. When with return of spontaneous circulation oxygen is re-offered to the ischemic organs, massive amounts of reactive oxygen species (ROS) are produced. These ROS can further increase the damage to the myocardium and brain (reperfusion injury). Vitamin C is the primary circulating antioxidant. It scavenges free radicals and reduces the production of ROS. In a recent study we demonstrated that vitamin C plasma levels are deficient in ~60% of the patients after cardiac arrest, probably due to massive consumption. Vitamin C deficiency reduces the protection against oxidative stress. Intravenous supplementation is needed to restore deficiency and the antioxidative effect of vitamin C is much more potent if it is administered in a supraphysiological dose (≥ 3 g per day). Its strong antioxidative effect may reduce damage to the circulation and to brain, heart and other organs. Beneficial effects of high dose i.v. vitamin C after cardiac arrest have been demonstrated in preclinical studies, but not in patients.
Read full original descriptionShow less
The investigators hypothesize that vitamin C can reduce organ damage, especially cerebral injury, if administered for a short period as a high i.v. dose during the very early phase of reperfusion after cardiac arrest.
Objectives:
* To determine whether an early high dose i.v. vitamin C can improve organ function, especially neurological outcome, in patients after cardiac arrest * To explore the optimal dosing regimen for high dose i.v. vitamin C * To investigate in vitro the difference in effect of plasma obtained from post cardiac arrest patients treated with placebo, 3 gr/day or 10 gr/day vitamin C on endothelial cell viability and underlying oxidative pathways.
The 3 groups in the trial
- Placebo groupPlacebo, for comparison
Group 1 will be treated with placebos for 4 days. All patients will receive Thiamine 200 mg q 12 hourly for 4 days to limit the conversion of vitamin C to oxalate
Treatment: Thiamine and Placebos
- Vitamin C - 3 gr/dayExisting treatment, for comparison
Group 2 will be treated with 1.5 gr Vitamin C b.i.d. (3 gr/day) for 4 days. All patients will receive Thiamine 200 mg q 12 hourly for 4 days to limit the conversion of vitamin C to oxalate
Treatment: Vitamin C and Thiamine
- Vitamin C - 10 gr/dayExisting treatment, for comparison
Group 3 will be treated with 5 gr Vitamin C b.i.d. (10 gr/day) for 4 days. All patients will receive Thiamine 200 mg q 12 hourly for 4 days to limit the conversion of vitamin C to oxalate
Treatment: Vitamin C and Thiamine
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Early High-dose Vitamin C in Post-cardiac Arrest Syndrome
- Publications
- Record updated
- 10 March 2025